Silpol 120 mg/5 ml (Oral Suspension)
60 ml bottle: ৳ 35.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Paracetamol |
| Company | Silco pharmaceutical ltd |
Title
- Silpol 120 mg/5 ml Suspension
Categories
- Medicine
- Healthcare
- Pain Relief
- Fever Relief
- Cold & Flu Relief
- Analgesic
- Antipyretic
Description
- Silpol is indicated for fever, common cold and influenza, headache, toothache, earache, bodyache, myalgia, neuralgia, dysmenorrhoea, sprains, colic pain, back pain, post-operative pain, postpartum pain, inflammatory pain and post vaccination pain in children. It is also indicated for rheumatic & osteoarthritic pain and stiffness of joints.
- Paracetamol has analgesic and antipyretic properties with weak anti-inflammatory activity. Paracetamol (Acetaminophen) is thought to act primarily in the CNS, increasing the pain threshold by inhibiting both isoforms of cyclooxygenase, COX-1, COX-2, and COX-3 enzymes involved in prostaglandin (PG) synthesis.
- Silpol is contraindicated in known hypersensitivity to Paracetamol.
- Side effects of Silpol are usually mild, though haematological reactions including thrombocytopenia, leucopenia, pancytopenia, neutropenia, and agranulocytosis have been reported. Pancreatitis, skin rashes, and other allergic reactions occur occasionally.
- Epidemiological studies in human pregnancy have shown no ill effects due to Paracetamol used in the recommended dosage, but patients should follow the advice of their doctor regarding its use. Paracetamol is excreted in breast milk, but not in a clinically significant amount. Available published data do not contraindicate breast feeding.
- Care is advised in the administration of Silpol to patients with severe renal or severe hepatic impairment. The hazard of overdose is greater in those with non-cirrhotic alcoholic liver disease. Do not exceed the stated dose. Patients should be advised not to take other Silpol-containing products concurrently. Silpol should only be used by the patient for whom it is prescribed when clearly necessary.
- Liver damage is possible in adults who have taken 10 g or more of Silpol.
- Paracetamol should be kept in a dry place away from light and heat, and out of the reach of children.
Dimensions
- 120 mg/5 ml Suspension
- Available in tablets, extended release tablets, syrup/suspension, suppository, and pediatric drop forms
- Tablet with actizorb technology dissolves up to five times faster than standard Paracetamol tablets
Color Options
- Not applicable
Functions
- Fever relief
- Pain relief
- Inflammation reduction
- Analgesic effect
- Antipyretic effect
Materials
- Acetaminophen
- Paracetamol
- Actizorb technology
Technical Specifications
- Maximum dosage for adults: 4 gm (8 tablets) daily
- Maximum dosage for children (6-12 years): 2.6 gm/day
- Extended release tablet maximum dosage: 6 tablets in any 24 hours
- Pediatric drop maximum dosage: 5 doses daily for a maximum of 5 days
- Tablet with actizorb technology maximum dosage for adults and children (aged 12 years and over): 8 caplets in 24 hours
Design Elements
- Chemical Structure
- Molecular Formula: C8H9NO2
- Fast acting technology
- Therapeutic Class: Non opioid analgesics
Usability Features
- Suitable for patients who cannot tolerate aspirin or other analgesics
- Recommended for patients with liver disease
- Should be taken with food or milk to prevent upset stomach
- Do not take indigestion remedies (antacids) within two hours of taking Silpol
- Avoid consuming alcohol while taking Silpol
- Doctor monitoring for long-term treatment
Storage Conditions
- Keep in a dry place away from light and heat
- Keep out of the reach of children
Interaction
- Patients who have taken barbiturates, tricyclic antidepressants and alcohol may show diminished ability to metabolize large doses of Silpol.
- Alcohol can increase the hepatotoxicity of Silpol overdosage.
- Chronic ingestion of anticonvulsants or oral steroid contraceptives induce liver enzymes and may prevent attainment of therapeutic Silpol levels by increasing first-pass metabolism or clearance.